Investing at the biopharma frontier

Rebecca Sykes, CFA, Global Industry Analyst
2024-11-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1414387544

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.

The innovations happening in the biopharma industry today are some of the most exciting I’ve seen in my career

Rebecca Sykes, CFA
Portfolio Manager and Global Industry Analyst

Expert

Related insights

Showing of Insights Posts
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech IPOs in 2025: Quantity, quality, and best practices

Continue reading
event
4 min
Article
2025-08-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Built to last? Identifying durable health care start-ups

Continue reading
event
14 min
Article
2025-05-23
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Read next